Global Hemophilia Gene Therapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Global Hemophilia Gene Therapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Table of Contents
1 Study Coverage
1.1 Hemophilia Gene Therapy Product Introduction
1.2 Market by Type
1.2.1 Global Hemophilia Gene Therapy Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Hemophilia A
1.2.3 Hemophilia B
1.3 Market by Application
1.3.1 Global Hemophilia Gene Therapy Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Hemophilia A Gene Therapy
1.3.3 Hemophilia B Gene Therapy
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Hemophilia Gene Therapy Market Size Estimates and Forecasts
2.2 Hemophilia Gene Therapy Market Size by Region: 2022 Versus 2028
2.2.1 Global Hemophilia Gene Therapy Revenue by Region: 2017-2022
2.2.2 Global Hemophilia Gene Therapy Revenue Forecast by Region (2023-2028)
2.2.3 Global Hemophilia Gene Therapy Revenue Market Share by Region (2017-2028)
3 Global Hemophilia Gene Therapy by Company
3.1 Global Hemophilia Gene Therapy Revenue by Company (2017-2022)
3.2 Global Hemophilia Gene Therapy Revenue Share by Company (2017-2022)
3.3 Competitive Landscape
3.3.1 Key Hemophilia Gene Therapy Companies around the World: Ranking by Revenue
3.3.2 Global Hemophilia Gene Therapy Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.3.3 Global Hemophilia Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.4 Global Hemophilia Gene Therapy Companies Headquarters & Product Type
3.4.1 Hemophilia Gene Therapy Companies Headquarters
3.4.2 Global Hemophilia Gene Therapy Companies Product & Service
3.4.3 Date of International Companies Enter into Hemophilia Gene Therapy Market
3.5 Global Hemophilia Gene Therapy Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Spark Therapeutics
4.1.1 Spark Therapeutics Corporation Information
4.1.2 Spark Therapeutics Description, Business Overview
4.1.3 Spark Therapeutics Hemophilia Gene Therapy Products Offered
4.1.4 Spark Therapeutics Hemophilia Gene Therapy Revenue and Gross Margin (2017-2022)
4.1.5 Spark Therapeutics Hemophilia Gene Therapy Revenue by Product in 2021
4.1.6 Spark Therapeutics Hemophilia Gene Therapy Revenue by Application in 2021
4.1.7 Spark Therapeutics Hemophilia Gene Therapy Revenue by Geographic Area in 2021
4.1.8 Spark Therapeutics Recent Developments
4.2 Ultragenyx
4.2.1 Ultragenyx Corporation Information
4.2.2 Ultragenyx Description, Business Overview
4.2.3 Ultragenyx Hemophilia Gene Therapy Products Offered
4.2.4 Ultragenyx Hemophilia Gene Therapy Revenue and Gross Margin (2017-2022)
4.2.5 Ultragenyx Hemophilia Gene Therapy Revenue by Product in 2021
4.2.6 Ultragenyx Hemophilia Gene Therapy Revenue by Application in 2021
4.2.7 Ultragenyx Hemophilia Gene Therapy Revenue by Geographic Area in 2021
4.2.8 Ultragenyx Recent Developments
4.3 Shire PLC
4.3.1 Shire PLC Corporation Information
4.3.2 Shire PLC Description, Business Overview
4.3.3 Shire PLC Hemophilia Gene Therapy Products Offered
4.3.4 Shire PLC Hemophilia Gene Therapy Revenue and Gross Margin (2017-2022)
4.3.5 Shire PLC Hemophilia Gene Therapy Revenue by Product in 2021
4.3.6 Shire PLC Hemophilia Gene Therapy Revenue by Application in 2021
4.3.7 Shire PLC Hemophilia Gene Therapy Revenue by Geographic Area in 2021
4.3.8 Shire PLC Recent Developments
4.4 Sangamo Therapeutics
4.4.1 Sangamo Therapeutics Corporation Information
4.4.2 Sangamo Therapeutics Description, Business Overview
4.4.3 Sangamo Therapeutics Hemophilia Gene Therapy Products Offered
4.4.4 Sangamo Therapeutics Hemophilia Gene Therapy Revenue and Gross Margin (2017-2022)
4.4.5 Sangamo Therapeutics Hemophilia Gene Therapy Revenue by Product in 2021
4.4.6 Sangamo Therapeutics Hemophilia Gene Therapy Revenue by Application in 2021
4.4.7 Sangamo Therapeutics Hemophilia Gene Therapy Revenue by Geographic Area in 2021
4.4.8 Sangamo Therapeutics Recent Developments
4.5 Bioverativ
4.5.1 Bioverativ Corporation Information
4.5.2 Bioverativ Description, Business Overview
4.5.3 Bioverativ Hemophilia Gene Therapy Products Offered
4.5.4 Bioverativ Hemophilia Gene Therapy Revenue and Gross Margin (2017-2022)
4.5.5 Bioverativ Hemophilia Gene Therapy Revenue by Product in 2021
4.5.6 Bioverativ Hemophilia Gene Therapy Revenue by Application in 2021
4.5.7 Bioverativ Hemophilia Gene Therapy Revenue by Geographic Area in 2021
4.5.8 Bioverativ Recent Developments
4.6 BioMarin
4.6.1 BioMarin Corporation Information
4.6.2 BioMarin Description, Business Overview
4.6.3 BioMarin Hemophilia Gene Therapy Products Offered
4.6.4 BioMarin Hemophilia Gene Therapy Revenue and Gross Margin (2017-2022)
4.6.5 BioMarin Hemophilia Gene Therapy Revenue by Product in 2021
4.6.6 BioMarin Hemophilia Gene Therapy Revenue by Application in 2021
4.6.7 BioMarin Hemophilia Gene Therapy Revenue by Geographic Area in 2021
4.6.8 BioMarin Recent Development
4.7 uniQure
4.7.1 uniQure Corporation Information
4.7.2 uniQure Description, Business Overview
4.7.3 uniQure Hemophilia Gene Therapy Products Offered
4.7.4 uniQure Hemophilia Gene Therapy Revenue and Gross Margin (2017-2022)
4.7.5 uniQure Hemophilia Gene Therapy Revenue by Product in 2021
4.7.6 uniQure Hemophilia Gene Therapy Revenue by Application in 2021
4.7.7 uniQure Hemophilia Gene Therapy Revenue by Geographic Area in 2021
4.7.8 uniQure Recent Development
4.8 Freeline Therapeutics
4.8.1 Freeline Therapeutics Corporation Information
4.8.2 Freeline Therapeutics Description, Business Overview
4.8.3 Freeline Therapeutics Hemophilia Gene Therapy Products Offered
4.8.4 Freeline Therapeutics Hemophilia Gene Therapy Revenue and Gross Margin (2017-2022)
4.8.5 Freeline Therapeutics Hemophilia Gene Therapy Revenue by Product in 2021
4.8.6 Freeline Therapeutics Hemophilia Gene Therapy Revenue by Application in 2021
4.8.7 Freeline Therapeutics Hemophilia Gene Therapy Revenue by Geographic Area in 2021
4.8.8 Freeline Therapeutics Recent Development
5 Breakdown Data by Type
5.1 Global Hemophilia Gene Therapy Revenue by Type (2017-2022)
5.2 Global Hemophilia Gene Therapy Revenue Forecast by Type (2023-2028)
5.3 Hemophilia Gene Therapy Revenue Marke Share by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Hemophilia Gene Therapy Revenue by Application (2017-2022)
6.2 Global Hemophilia Gene Therapy Revenue Forecast by Application (2023-2028)
6.3 Hemophilia Gene Therapy Revenue Market Share by Application (2017-2028)
7 North America
7.1 North America Hemophilia Gene Therapy Market Size YoY Growth 2017-2028
7.2 North America Hemophilia Gene Therapy Market Facts & Figures by Country (2017-2028)
7.3 North America Hemophilia Gene Therapy Revenue by Type (2017-2022)
7.4 North America Hemophilia Gene Therapy Revenue by Application (2017-2022)
8 Asia-Pacific
8.1 Asia-Pacific Hemophilia Gene Therapy Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Hemophilia Gene Therapy Market Facts & Figures by Region (2017-2028)
8.3 Asia-Pacific Hemophilia Gene Therapy Revenue by Type (2017-2022)
8.4 Asia-Pacific Hemophilia Gene Therapy Revenue by Application (2017-2022)
9 Europe
9.1 Europe Hemophilia Gene Therapy Market Size YoY Growth 2017-2028
9.2 Europe Hemophilia Gene Therapy Market Facts & Figures by Country (2017-2028)
9.3 Europe Hemophilia Gene Therapy Revenue by Type (2017-2022)
9.4 Europe Hemophilia Gene Therapy Revenue by Application (2017-2022)
10 Latin America
10.1 Latin America Hemophilia Gene Therapy Market Size YoY Growth 2017-2028
10.2 Latin America Hemophilia Gene Therapy Market Facts & Figures by Country (2017-2028)
10.3 Latin America Hemophilia Gene Therapy Revenue by Type (2017-2022)
10.4 Latin America Hemophilia Gene Therapy Revenue by Application (2017-2022)
11 Middle East and Africa
11.1 Middle East and Africa Hemophilia Gene Therapy Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Hemophilia Gene Therapy Market Facts & Figures by Country (2017-2028)
11.3 Middle East and Africa Hemophilia Gene Therapy Revenue by Type (2017-2022)
11.4 Middle East and Africa Hemophilia Gene Therapy Revenue by Application (2017-2022)
12 Supply Chain and Sales Channel Analysis
12.1 Hemophilia Gene Therapy Supply Chain Analysis
12.2 Hemophilia Gene Therapy Key Raw Materials and Upstream Suppliers
12.3 Hemophilia Gene Therapy Clients Analysis
12.4 Hemophilia Gene Therapy Sales Channel and Sales Model Analysis
12.4.1 Hemophilia Gene Therapy Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Hemophilia Gene Therapy Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Hemophilia Gene Therapy Distributors
13 Market Dynamics
13.1 Hemophilia Gene Therapy Industry Trends
13.2 Hemophilia Gene Therapy Market Drivers
13.3 Hemophilia Gene Therapy Market Challenges
13.4 Hemophilia Gene Therapy Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Hemophilia Gene Therapy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Companies of Hemophilia A
Table 3. Major Companies of Hemophilia B
Table 4. Global Hemophilia Gene Therapy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Hemophilia Gene Therapy Market Size by Region (US$ Million): 2022 VS 2028
Table 6. Global Hemophilia Gene Therapy Revenue by Region (2017-2022) & (US$ Million)
Table 7. Global Hemophilia Gene Therapy Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 8. Hemophilia Gene Therapy Revenue by Company (2017-2022) & (US$ Million)
Table 9. Hemophilia Gene Therapy Revenue Share by Company (2017-2022)
Table 10. Ranking of Global Top Hemophilia Gene Therapy Players by Revenue (US$ Million) in 2021
Table 11. Global Hemophilia Gene Therapy Companies Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 12. Global Hemophilia Gene Therapy by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hemophilia Gene Therapy as of 2021)
Table 13. Global Hemophilia Gene Therapy Companies Headquarters
Table 14. Global Hemophilia Gene Therapy Companies Product & Service
Table 15. Date of International Companies Enter into Hemophilia Gene Therapy Market
Table 16. Global Hemophilia Gene Therapy Mergers & Acquisitions, Expansion Plans
Table 17. Spark Therapeutics Corporation Information
Table 18. Spark Therapeutics Description and Business Overview
Table 19. Spark Therapeutics Hemophilia Gene Therapy Revenue (US$ Million) and Gross Margin (2017-2022)
Table 20. Spark Therapeutics Hemophilia Gene Therapy Product
Table 21. Spark Therapeutics Hemophilia Gene Therapy Revenue Proportion of Hemophilia Gene Therapy by Product in 2021
Table 22. Spark Therapeutics Hemophilia Gene Therapy Revenue Proportion of Hemophilia Gene Therapy by Application in 2021
Table 23. Spark Therapeutics Hemophilia Gene Therapy Revenue Proportion of Hemophilia Gene Therapy by Geographic Area in 2021
Table 24. Spark Therapeutics Recent Development
Table 25. Ultragenyx Corporation Information
Table 26. Ultragenyx Description and Business Overview
Table 27. Ultragenyx Hemophilia Gene Therapy Revenue (US$ Million) and Gross Margin (2017-2022)
Table 28. Ultragenyx Hemophilia Gene Therapy Product
Table 29. Ultragenyx Hemophilia Gene Therapy Revenue Proportion of Hemophilia Gene Therapy by Product in 2021
Table 30. Ultragenyx Hemophilia Gene Therapy Revenue Proportion of Hemophilia Gene Therapy by Application in 2021
Table 31. Ultragenyx Hemophilia Gene Therapy Revenue Proportion of Hemophilia Gene Therapy by Geographic Area in 2021
Table 32. Ultragenyx Recent Development
Table 33. Shire PLC Corporation Information
Table 34. Shire PLC Description and Business Overview
Table 35. Shire PLC Hemophilia Gene Therapy Revenue (US$ Million) and Gross Margin (2017-2022)
Table 36. Shire PLC Hemophilia Gene Therapy Product
Table 37. Shire PLC Hemophilia Gene Therapy Revenue Proportion of Hemophilia Gene Therapy by Product in 2021
Table 38. Shire PLC Hemophilia Gene Therapy Revenue Proportion of Hemophilia Gene Therapy by Application in 2021
Table 39. Shire PLC Hemophilia Gene Therapy Revenue Proportion of Hemophilia Gene Therapy by Geographic Area in 2021
Table 40. Shire PLC Recent Development
Table 41. Sangamo Therapeutics Corporation Information
Table 42. Sangamo Therapeutics Description and Business Overview
Table 43. Sangamo Therapeutics Hemophilia Gene Therapy Revenue (US$ Million) and Gross Margin (2017-2022)
Table 44. Sangamo Therapeutics Hemophilia Gene Therapy Product
Table 45. Sangamo Therapeutics Hemophilia Gene Therapy Revenue Proportion of Hemophilia Gene Therapy by Product in 2021
Table 46. Sangamo Therapeutics Hemophilia Gene Therapy Revenue Proportion of Hemophilia Gene Therapy by Application in 2021
Table 47. Sangamo Therapeutics Hemophilia Gene Therapy Revenue Proportion of Hemophilia Gene Therapy by Geographic Area in 2021
Table 48. Sangamo Therapeutics Recent Development
Table 49. Bioverativ Corporation Information
Table 50. Bioverativ Description and Business Overview
Table 51. Bioverativ Hemophilia Gene Therapy Revenue (US$ Million) and Gross Margin (2017-2022)
Table 52. Bioverativ Hemophilia Gene Therapy Product
Table 53. Bioverativ Hemophilia Gene Therapy Revenue Proportion of Hemophilia Gene Therapy by Product in 2021
Table 54. Bioverativ Hemophilia Gene Therapy Revenue Proportion of Hemophilia Gene Therapy by Application in 2021
Table 55. Bioverativ Hemophilia Gene Therapy Revenue Proportion of Hemophilia Gene Therapy by Geographic Area in 2021
Table 56. Bioverativ Recent Development
Table 57. BioMarin Corporation Information
Table 58. BioMarin Description and Business Overview
Table 59. BioMarin Hemophilia Gene Therapy Revenue (US$ Million) and Gross Margin (2017-2022)
Table 60. BioMarin Hemophilia Gene Therapy Product
Table 61. BioMarin Hemophilia Gene Therapy Revenue Proportion of Hemophilia Gene Therapy by Product in 2021
Table 62. BioMarin Hemophilia Gene Therapy Revenue Proportion of Hemophilia Gene Therapy by Application in 2021
Table 63. BioMarin Hemophilia Gene Therapy Revenue Proportion of Hemophilia Gene Therapy by Geographic Area in 2021
Table 64. uniQure Corporation Information
Table 65. uniQure Description and Business Overview
Table 66. uniQure Hemophilia Gene Therapy Revenue (US$ Million) and Gross Margin (2017-2022)
Table 67. uniQure Hemophilia Gene Therapy Product
Table 68. uniQure Hemophilia Gene Therapy Revenue Proportion of Hemophilia Gene Therapy by Product in 2021
Table 69. uniQure Hemophilia Gene Therapy Revenue Proportion of Hemophilia Gene Therapy by Application in 2021
Table 70. uniQure Hemophilia Gene Therapy Revenue Proportion of Hemophilia Gene Therapy by Geographic Area in 2021
Table 71. Freeline Therapeutics Corporation Information
Table 72. Freeline Therapeutics Description and Business Overview
Table 73. Freeline Therapeutics Hemophilia Gene Therapy Revenue (US$ Million) and Gross Margin (2017-2022)
Table 74. Freeline Therapeutics Hemophilia Gene Therapy Product
Table 75. Freeline Therapeutics Hemophilia Gene Therapy Revenue Proportion of Hemophilia Gene Therapy by Product in 2021
Table 76. Freeline Therapeutics Hemophilia Gene Therapy Revenue Proportion of Hemophilia Gene Therapy by Application in 2021
Table 77. Freeline Therapeutics Hemophilia Gene Therapy Revenue Proportion of Hemophilia Gene Therapy by Geographic Area in 2021
Table 78. Global Hemophilia Gene Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 79. Global Hemophilia Gene Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 80. Global Hemophilia Gene Therapy Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 81. North America Hemophilia Gene Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 82. North America Hemophilia Gene Therapy Revenue by Country (2023-2028) & (US$ Million)
Table 83. North America Hemophilia Gene Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 84. North America Hemophilia Gene Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 85. Asia-Pacific Hemophilia Gene Therapy Revenue by Region (2017-2028) & (US$ Million)
Table 86. Asia-Pacific Hemophilia Gene Therapy Revenue by Region (2023-2028) & (US$ Million)
Table 87. Asia-Pacific Hemophilia Gene Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 88. Asia-Pacific Hemophilia Gene Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 89. Europe Hemophilia Gene Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 90. Europe Hemophilia Gene Therapy Revenue by Country (2023-2028) & (US$ Million)
Table 91. Europe Hemophilia Gene Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 92. Europe Hemophilia Gene Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 93. Latin America Hemophilia Gene Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Hemophilia Gene Therapy Revenue by Country (2023-2028) & (US$ Million)
Table 95. Latin America Hemophilia Gene Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 96. Latin America Hemophilia Gene Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Hemophilia Gene Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Hemophilia Gene Therapy Revenue by Country (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Hemophilia Gene Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Hemophilia Gene Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 101. Hemophilia Gene Therapy Key Raw Materials, Industry Status and Trend
Table 102. Hemophilia Gene Therapy Key Raw Materials and Upstream Suppliers
Table 103. Hemophilia Gene Therapy Clients Status and Trend
Table 104. Hemophilia Gene Therapy Typical Clients
Table 105. Hemophilia Gene Therapy Distributors
Table 106. Hemophilia Gene Therapy Market Trends
Table 107. Hemophilia Gene Therapy Market Drivers
Table 108. Hemophilia Gene Therapy Market Challenges
Table 109. Hemophilia Gene Therapy Market Restraints
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Hemophilia Gene Therapy Product Picture
Figure 2. Global Hemophilia Gene Therapy Revenue Market Share by Type in 2021 & 2028
Figure 3. Hemophilia A Product Picture
Figure 4. Hemophilia B Product Picture
Figure 5. Global Hemophilia Gene Therapy Revenue Market Share by Application in 2021 & 2028
Figure 6. Hemophilia A Gene Therapy
Figure 7. Hemophilia B Gene Therapy
Figure 8. Hemophilia Gene Therapy Report Years Considered
Figure 9. Global Hemophilia Gene Therapy Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Hemophilia Gene Therapy Market Size 2017-2028 (US$ Million)
Figure 11. Global Hemophilia Gene Therapy Market Size Market Share by Region: 2022 Versus 2028
Figure 12. Global Hemophilia Gene Therapy Revenue Market Share by Region (2017-2028)
Figure 13. Hemophilia Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 14. Global Hemophilia Gene Therapy Revenue Market Share Forecast by Type (2017-2028)
Figure 15. Global Hemophilia Gene Therapy Revenue Market Share Forecast by Application (2017-2028)
Figure 16. North America Hemophilia Gene Therapy Revenue 2017-2028 (US$ Million)
Figure 17. North America Hemophilia Gene Therapy Revenue Market Share by Type (2017-2022)
Figure 18. North America Hemophilia Gene Therapy Revenue Market Share by Application (2017-2022)
Figure 19. Asia-Pacific Hemophilia Gene Therapy Revenue 2017-2028 (US$ Million)
Figure 20. Asia-Pacific Hemophilia Gene Therapy Revenue Market Share by Region (2017-2028)
Figure 21. Asia-Pacific Hemophilia Gene Therapy Revenue Market Share by Type (2017-2022)
Figure 22. Asia-Pacific Hemophilia Gene Therapy Revenue Market Share by Application (2017-2022)
Figure 23. Europe Hemophilia Gene Therapy Revenue Growth Rate 2017-2028 (US$ Million)
Figure 24. Europe Hemophilia Gene Therapy Revenue Market Share by Country (2017-2028)
Figure 25. Europe Hemophilia Gene Therapy Revenue Market Share by Type (2017-2022)
Figure 26. Europe Hemophilia Gene Therapy Revenue Market Share by Application (2017-2022)
Figure 27. Latin America Hemophilia Gene Therapy Revenue Growth Rate 2017-2028 (US$ Million)
Figure 28. Latin America Hemophilia Gene Therapy Revenue Market Share by Country (2017-2022)
Figure 29. Latin America Hemophilia Gene Therapy Revenue Market Share by Type (2017-2022)
Figure 30. Latin America Hemophilia Gene Therapy Revenue Market Share by Application (2017-2022)
Figure 31. Middle East and Africa Hemophilia Gene Therapy Revenue Growth Rate 2017-2028 (US$ Million)
Figure 32. Middle East and Africa Hemophilia Gene Therapy Revenue Market Share by Country (2017-2028)
Figure 33. Middle East and Africa Hemophilia Gene Therapy Revenue Market Share by Type (2017-2022)
Figure 34. Middle East and Africa Hemophilia Gene Therapy Revenue Market Share by Application (2017-2022)
Figure 35. Hemophilia Gene Therapy Supply Chain (Upstream and Downstream Market)
Figure 36. Global Production Market Share of Hemophilia Gene Therapy Raw Materials by Region in 2021
Figure 37. Hemophilia Gene Therapy Distribution Channels
Figure 38. Global Hemophilia Gene Therapy Percentage 2017-2028: Indirect Sales VS Direct Sales
Figure 39. Global Hemophilia Gene Therapy Percentage 2017-2028: Online Sales VS Offline Sales
Figure 40. Bottom-up and Top-down Approaches for This Report
Figure 41. Data Triangulation
Figure 42. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Gene Therapy Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 111

According to our LPI (LP Information) latest study, the global Gene Therapy market size was valued at US$ 6923.7 million in 2023. With growing demand in downstream market, the Gene Therapy is forecast to a readjusted size of US$ 40340 million by 2030 with a CAGR of 28.6% during review period. The research report highlights the growth potential of the global Gene Therapy market. Gene Therapy are expected to show stable growth in the future market. However, product differentiation, reducin......

Global Hemophilia Gene Therapy Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90

According to our LPI (LP Information) latest study, the global Hemophilia Gene Therapy market size was valued at US$ million in 2023. With growing demand in downstream market, the Hemophilia Gene Therapy is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Hemophilia Gene Therapy market. Hemophilia Gene Therapy are expected to show stable growth in the future market. However, produc......

Global Cell and Gene Therapy CDMO Market (2024 Edition): Analysis By Type (Cell Therapy, Gene Therapy, Gene-modified Cell Therapies), Application (Clinical, Pre-clinical), Indication, By Region, By Country: Market Insights and Forecast (2024-2029)

Published: 01-Jan-2024        Price: US 2450 Onwards        Pages: 260

Executive Summary Azoth Analytics has released a research report titled "Global Cell and Gene Therapy CDMO Market (2024 Edition)" which provides a complete analysis of the Global Cell and Gene Therapy CDMO Market industry in terms of market segmentation by Type (Cell Therapy, Gene Therapy, Gene-modified Cell Therapies), Application (Clinical, Pre-clinical), Indication (Oncology Diseases, Infectious Diseases, Neurological Disorder, Others) for the historical period of 2019-2022, es......

Global Hemophilia Gene Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 88

According to our (Global Info Research) latest study, the global Hemophilia Gene Therapy market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Hemophilia is a rare bleeding disorder in which the blood does not clot normally. Hemophilia is a monogenic disease (a disease that is caused by a genetic defect in a single gene). There are two types of hemophilia caused by mutations in genes that encode pr......

Global Gene Expression Analysis Market Status and Outlook 2023-2028

Published: 26-Dec-2023        Price: US 3160 Onwards        Pages: 102

Gene expression analyses study the occurrence or activity of the formation of a gene product from its coding gene. It is a sensitive indicator of biological activity wherein a changing gene expression pattern is reflected in a change of biological process. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This ......

Global Gene Expression Analysis Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 125

Market Overview of Global Gene Expression Analysis market: According to our latest research, the global Gene Expression Analysis market looks promising in the next 5 years. As of 2022, the global Gene Expression Analysis market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global......

Global Animal Genetics Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 120

Report Overview: Animal Genetics is a branch of genetics that studies heredity and variation chiefly in farm animals but also in domestic and wild animals. It is based on general genetic principles and concepts, and it mainly uses the hybrid, cytological, population, ontogenetic, mathematical-statistical, and twin methods of general genetics. Animal breeding or genetics is the area of science where experts are trying to steer the frequency of certain genes by combining the most super......

Global Animal Genetics Market Status and Outlook 2023-2028

Published: 24-Nov-2023        Price: US 3160 Onwards        Pages: 105

Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......

Gene Therapy Collaboration and Licensing Deals 2016-2023

Published: 01-Nov-2023        Price: US 3995 Onwards        Pages: 450

Gene Therapy Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the gene therapy deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of gene therapy deals from 2016 to 2023. The report provides a detailed understanding and analysis of how and why companies enter gene therapy deals. These deals tend to be multicomponent, starting with collaborative R&D, and ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs